Read Time:7 Second
Data from a Phase 1 trial is the latest bullish news from the biotech that may offer cheap entry to weight-loss mania.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
